Mindbreeze and Austinat & Haarhaus are teaming up to take on intelligent information provision. The communications technology specialist helps customers streamline their digital workplaces and optimize workflows.
The former Little Mix singer opened up about 'mentally bullying' herself about her weight.
GlaxoSmithKline will extend a trial testing an experimental rheumatoid arthritis drug on patients suffering from pneumonia related to COVID-19 to focus on the elderly as it seeks to firm up encouraging findings so far. A trial started in May last year has shown that the drug known as otilimab helps patients over 70 with severe COVID-19 get off mechanical ventilation or high-flow oxygen support faster, the British drugmaker said on Thursday. The benefit for younger trial participants was not clear enough to merit further investigation, prompting the re-focus on the elderly in a follow-up trial with a targeted 350 participants.
Sontiq delivers visibility and insight of digital reputation and personal online brand through patent-pending online reputation management solution.
DS Smith is now offering grocery stores and consumers Greentote, the first 100% recyclable and stable container to replace plastic shopping bags.
Britain is conducting a review of its financial rulebooks and policies to see how it can keep its 130 billion pound ($184 billion) finance sector competitive after Brexit left it largely cut off from the European Union. The government is due to issue papers in the coming days outlining its approach to financial technology (fintech) and capital markets, while further down the line it's expected to propose changes to the funds and insurance sectors. Britain's finance ministry is reviewing financial regulation and insurance capital rules, with minister Rishi Sunak raising the prospect of a "Big Bang 2.0" to maintain the City's competitiveness, a reference to liberalisation of trading in the 1980s.
"La campagna di vaccinazione contro l’epidemia Covid sta registrando un confortante incremento. Da lunedì 22 febbraio sono state effettuate in media oltre 100mila somministrazioni al giorno e ieri, mercoledì 24 febbraio, è stato raggiunto il picco di 102.433 dosi". Lo rende noto l’ufficio stampa del Commissario Straordinario per l’Emergenza Covid. Quanto all'inchiesta sulle mascherine la Struttura commissariale tiene a precisare che "la totalità dei dispositivi forniti al riguardo è stata acquistata e distribuita ai sensi della normativa vigente. Più specificamente, l’art. 5 bis del DL 18/2020 autorizza l’acquisizione e l’immissione in commercio da parte della Protezione civile e del Commissario straordinario di dispositivi di protezione individuale, purché essi siano stati sottoposti alla validazione del Comitato Tecnico Scientifico e abbiano ricevuto parere positivo", si legge in una nota della struttura commissariale per l'emergenza Covid. "Tutti i dispositivi di cui si parla sono stati sottoposti con esito favorevole a questa procedura come risulta dai relativi verbali di approvazione del Cts - sottolinea la struttura commissariale - Inoltre, la totalità dei dispositivi provenienti dall’estero vengono validati, di nuovo ai sensi di legge, dalle strutture preposte dell’Agenzia delle dogane che, solo dopo averne verificata la compatibilità con le norme vigenti, ne autorizza lo sdoganamento. Anche ai sensi di un protocollo sottoscritto dalla Struttura commissariale con l’Agenzia delle Dogane, sin dall’inizio della emergenza, tali verifiche sono state esperite". "Quanto alla documentazione cui si fa riferimento nei suddetti articoli di stampa, ovvero quella fatta pervenire unilateralmente e senza alcuna richiesta alla struttura commissariale il 2 dicembre 2020 dai fornitori, era nella sua totalità già nella disponibilità degli uffici del Commissario e messa a disposizione degli inquirenti", concludono gli uffici del Commissario Straordinario per l’Emergenza Covid, Domenico Arcuri.
EUSA Pharma (UK) Limited ("EUSA Pharma"), a global biopharmaceutical company focused on oncology and rare diseases, announced that the National Comprehensive Cancer Network® (NCCN®) has updated their Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for B-Cell Lymphomas to include siltuximab (SYLVANT®) as the preferred primary treatment for patients with human immunodeficiency virus–negative [HIV(-)] and human herpesvirus 8–negative [HHV-8(-)] multicentric Castleman disease (MCD), also known as idiopathic multicentric Castleman disease (iMCD), regardless of histopathologic subtype.1 Siltuximab is currently approved in more than 40 countries worldwide for the treatment of all histopathologic subtypes of iMCD, a rare, life-threatening and debilitating orphan condition of the lymph nodes and related tissues. 2,3 The update is based on a 2020 publication which demonstrated that there is insufficient evidence to guide treatment based solely on lymph node histopathologic subtype.4
The "India COVID-19 Vaccines Market - Growth, Demand, Trends, Opportunity, Forecasts (2021 - 2027)" report has been added to ResearchAndMarkets.com's offering.
The Global Probiotic Cosmetic Products Market size is expected to reach $400 Million by 2026, rising at a market growth of 11% CAGR during the forecast period. Probiotic skincare cosmetic products are considered as beauty products that help in increasing the healing benefits of good microorganisms present in our skin.New York, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Probiotic Cosmetic Products Market By Distribution Channel, By Product, By Region, Industry Analysis and Forecast, 2020 - 2026" - https://www.reportlinker.com/p06028130/?utm_source=GNW Such products are also in high demand as they control the natural immune response of the skin and create better skin immunity and resilience. The market of probiotic skincare cosmetic products is witnessing a rising growth graph as these products are really beneficial in maintaining bright skin and aid in preventing issues related to skin.The market of these products is dynamic with local and global players in the competition in order to gain a leading position. For attaining a competitive advantage over others, the people in this market are always in the pursuit of developing products that are profitable and have a positive impact on consumers. Manufacturers also strive to produce cosmetic products mixed with probiotics and other products to improve the quality of cosmetic products.The increasing adoption of probiotics as dietary supplement, probiotics witness a massive demand in the cosmetics category, hence boosting the growth of the market. These cosmetic products are beneficial and suitable to all skin types and can assist in reducing problems related to eczema, chronic inflammation, rosacea, and acne.The industry has been severely impacted by the global COVID-19 pandemic. Various governments have implemented different measures to contain the spread of virus such as Stay-home policy, lockdown measures, and store closures which caused a severe decline in sales. During the pandemic, one of the major observations is that the sentiment of consumers has shifted more toward basic skincare routines and necessities, thus reducing the demand for the probiotic products. Also, the present situation has encouraged customers to step back and choose mass skincare products, which are significantly cheaper and extensively available across all distribution channels.By Distribution ChannelBased on Distribution Channel, the market is segmented into Hypermarket & Supermarket, Pharmacy & Drug Store, E-commerce and other Distribution Channels. Hypermarket & supermarket acquired the maximum revenue share of the global probiotics cosmetic product market in 2019. The offline stores such as hypermarkets and supermarkets are planning to provide more shelf space to probiotic cosmetic products, which is anticipated to drive the segment growth. Several big retailers, like Sephora and Ulta Beauty, have contributed in giving offline experience to their customers. Sephora has a distinct category for the cosmetic range that showcase probiotics and other supplements.By ProductBased on Product, the market is segmented into Skin care and Hair Care. In 2019, the skin care segment emerged as the dominant segment and held the maximum market share of the global revenue. Probiotics are beneficial to skin problems, such as acne, wrinkles, blemishes, and others, which act as a catalyst for the segment growth. Awareness among people has been increased with respect to the clinically tested products and the effectiveness of probiotics cosmetics which helps to fuel the segment growth. In addition to it, increasing demand for products that will have minimum side effects is likely to boost the product demand in this segment.By RegionBased on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. In 2019, North America emerged as the leading region in the probiotics cosmetic product market. The increasing concerns about acne and different skin diseases are expected to boost the probiotics cosmetics demand in this region. Leading manufacturers are focused on product innovation in order to gain a competitive edge in the market.The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Estee Lauder Companies, Inc., L’Oreal Group, Unilever PLC, The Clorox Company, Health and Happiness (H&H) International Holdings Limited (Aurelia Probiotic Skincare), Esse Skincare, Tula Life, Inc., Eminence Organic Skin Care, Glowbiotics, Inc., and LaFlore Probiotic Skincare.Strategies deployed in Probiotic Cosmetic Products MarketNov-2020: L’Oreal signed a license agreement with Dutch biotech, RM Micreos. The agreement provided the former company the access to technology, which targets the bacteria responsible for skin conditions.Aug-2020: Estee Lauder Companies collaborated with Atropos Therapeutics, a biopharmaceutical company focused on discovering and developing drugs against aging disorders. The collaboration was focused on identifying new anti-ageing molecules and finding senomodulators from the botanical space for use in personal care products.Jul-2020: Tula partnered with Courtney Shields macro-influencer for the launch of new product named as Glow Hour. It is a brightening and neutralizing eye balm that blends all elements of beauty for a fresh, energized feel, inside and out.Apr-2020: Estee Lauder launched a new hybrid skincare and cosmetics product for the travel retail channel. The product is known as the new Futurist Hydra Rescue Moisturizing Makeup SPF 45. This product combines illuminating makeup with hydrating, skincare and offers full coverage.May-2019: Unilever completed the acquisition of Olly, San Francisco-based supplement brand. The acquisition complemented the two flagship categories of the company including beauty & personal care, and foods & refreshments.Mar-2019: L’Oreal partnered with uBiome, the leader in microbial genomics. Following this partnership, the companies aimed to carry out new research on the skin’s bacterial ecosystem. The new research would increase their knowledge of the impact that bacterial diversity has on skin health, and would focus on future product development at L’Oréal.Apr-2018: Esse Skincare expanded its product line with the addition of Esse Sensitive line Protect Oil. The product was designed to protect and remediate sensitive skins from environmental damaged.Feb-2018: Unilever acquired a minority stake in Gallinee, young French brand that uses a patented complex of prebiotics, probiotics, and postbiotics to care for sensitive skin. Following this acquisition, Unilever has taken its first step into the growing microbiome skincare market.Scope of the StudyMarket Segments covered in the Report:By Distribution Channel• Hypermarket & Supermarket• Pharmacy & Drug Store• E-commerce• Other Distribution ChannelsBy Product• Skin care• Hair CareBy Geography• North Americao USo Canadao Mexicoo Rest of North America• Europeo Germanyo UKo Franceo Russiao Spaino Italyo Rest of Europe• Asia Pacifico Chinao Japano Indiao South Koreao Singaporeo Malaysiao Rest of Asia Pacific• LAMEAo Brazilo Argentinao UAEo Saudi Arabiao South Africao Nigeriao Rest of LAMEACompanies Profiled• Estee Lauder Companies, Inc.• L’Oreal Group• Unilever PLC• The Clorox Company• Health and Happiness (H&H) International Holdings Limited (Aurelia Probiotic Skincare)• Esse Skincare• Tula Life, Inc.• Eminence Organic Skin Care• Glowbiotics, Inc.• LaFlore Probiotic SkincareUnique Offerings • Exhaustive coverage• Highest number of market tables and figures• Subscription based model available• Guaranteed best price• Assured post sales research support with 10% customization freeRead the full report: https://www.reportlinker.com/p06028130/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
Pity our students who would, in happier times, be sitting GCSEs and A-levels this summer. Or will it be sitting exams approximating to normal ones set by the exam boards and marked by teachers? After Gavin Williamson’s announcement today of what will replace normal exams, no one really knows.
Enlightened drug reforms are sweeping the US. Why is Britain so far behind?While other countries turn away from the futile ‘war on drugs’, politicians here are still falling for the ‘evil’ narcotics narrative ‘In November’s US presidential contest, voters from across the political spectrum chose to legalise recreational cannabis.’ A cannabis market in Los Angeles, California. Photograph: Richard Vogel/AP
Stop paying interest on large credit card purchases and find out how to use the convenient My Chase Plan tool.
New York City's luxury shopping district has taken a beating over the past 12 months. Will it recover?
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced that members of its senior management team are scheduled to participate in three upcoming virtual investor conferences.
Best Buy Co., Inc. (NYSE: BBY) today announced results for the 13-week fourth quarter ended January 30, 2021 ("Q4 FY21"), as compared to the 13-week fourth quarter ended February 1, 2020 ("Q4 FY20").
Otilimab demonstrated a potential clinical benefit in those aged between 70 and 80, the study suggested.
‘He’s begging us to do something, to take him out of here. That’s when you feel that you are just unable to help.’
Talaris today announced the appointment of four vice presidents in areas of strategic importance for the company.
BlueShore Financial reports a strong 2020 financial year with record profits (Net Operating Income) at $32 million, including a one-time gain of $9 million, and Return on Retained Earnings (RORE) of 15.5%. Assets Under Administration grew 4% to reach $6.5 billion, which includes growth of 15% in wealth management assets to reach $1.3 billion.